Sutro Biopharma Inc

NASDAQ:STRO  
15.57
-0.67 (-4.13%)
Earnings Announcements

Sutro Biopharma Reports Third Quarter 2021 Financial Results

Published: 11/10/2021 12:18 GMT
Sutro Biopharma Inc (STRO) - Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and Anticipated 2021 Milestones.
Q3 Revenue $8.5 Million.
Qtrly Net Loss per Share $0.67.
Q3 Earnings per Share View $-0.65, Revenue View $9.0 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $10.66 Million
Adjusted EPS is expected to be -$0.69

Next Quarter Revenue Guidance is expected to be $10.83 Million
Next Quarter EPS Guidance is expected to be -$0.72

More details on our Analysts Page.